GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IRIDEX Corp (NAS:IRIX) » Definitions » FCF Yield %

IRIX (IRIDEX) FCF Yield % : -24.46 (As of Dec. 13, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IRIDEX FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, IRIDEX's Trailing 12-Month Free Cash Flow is $-7.00 Mil, and Market Cap is $28.62 Mil. Therefore, IRIDEX's FCF Yield % for today is -24.46%.

The historical rank and industry rank for IRIDEX's FCF Yield % or its related term are showing as below:

IRIX' s FCF Yield % Range Over the Past 10 Years
Min: -42.68   Med: -10.28   Max: 12.3
Current: -24.46


During the past 13 years, the highest FCF Yield % of IRIDEX was 12.30%. The lowest was -42.68%. And the median was -10.28%.

IRIX's FCF Yield % is ranked worse than
80.05% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.06 vs IRIX: -24.46

IRIDEX's FCF Margin % for the quarter that ended in Sep. 2024 was -26.54%.


IRIDEX FCF Yield % Historical Data

The historical data trend for IRIDEX's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRIDEX FCF Yield % Chart

IRIDEX Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.16 -9.56 8.25 -30.51 -15.01

IRIDEX Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.08 -8.29 -13.64 -14.93 -42.23

Competitive Comparison of IRIDEX's FCF Yield %

For the Medical Devices subindustry, IRIDEX's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRIDEX's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's FCF Yield % distribution charts can be found below:

* The bar in red indicates where IRIDEX's FCF Yield % falls into.



IRIDEX FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

IRIDEX's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-6.854 / 45.670368
=-15.01%

IRIDEX's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.074 * 4 / 29.1137
=-42.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IRIDEX FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


IRIDEX FCF Yield % Related Terms

Thank you for viewing the detailed overview of IRIDEX's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


IRIDEX Business Description

Traded in Other Exchanges
N/A
Address
1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Executives
Nandini Devi director 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Robert Earle Grove director 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Topcon Corp 10 percent owner 75-1, HASUNUMA-CHO, ITABASHI-KU, TOKYO M0 174-8580
Topcon America Corp 10 percent owner 111 BAUER DRIVE, OAKLAND NJ 07426
Fuad Ahmad officer: Interim CFO 461 SOUTH MILPITAS BLVD., MILPITAS CA 95035
Doris Engibous director C/O NATUS MEDICAL INCORPORATED, 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Scott Shuda director 402 RAILROAD AVENUE, SUITE 201, DANVILLE CA 94526
Patrick Mercer officer: COO 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Ruediger Naumann-etienne director
Robert A Gunst director
David Bruce director, officer: President and CEO 1178 GLEN ROAD, LAFAYETTE CA 94549
Ken Ludlum director
Romeo R Dizon other: Vice President and Controller 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043

IRIDEX Headlines

From GuruFocus

Q3 2021 IRIDEX Corp Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q2 2022 IRIDEX Corp Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2023 IRIDEX Corp Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q2 2024 IRIDEX Corp Earnings Call Transcript

By GuruFocus News 10-09-2024

Q1 2022 IRIDEX Corp Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2024 IRIDEX Corp Earnings Call Transcript

By GuruFocus Research 05-15-2024